News at the Oxford-GSK Institute of Molecular and Computational Medicine
Our First Oxford-GSK Fellow
5 December 2023
We are delighted to welcome Steph Fowler - Our first Oxford-GSK IMCM Fellow and funded for five years. Steph has a background in fish physiology and originally trained as a molecular neuroscientist in Ottawa, Canada.
Our Team
31 August 2023
Talented scientists from across the world have joined our team. We have been honoured by the quality of applicants keen to join us as the institute. By the end of Q3 2023 we will have filled all of our posts. Not only are we bringing in new talent, we are also collaborating with with highly experienced colleagues from across GSK and Oxford University.
Progress in 2023 - putting data to work for patients
31 August 2023
Everything we do is to enable the delivery of targeted successful treatments to patients. Initially our focus is on diseases driven by neuro-immunological mechanisms including Alzheimer’s, Parkinson’s, and Amyotrophic Lateral Sclerosis (ALS).